I’ve been holding TSLA shares and selling covered calls on them for a couple of years. It’s a volatile stock — premiums are meaningful, but every time I think I understand the thesis, Elon drops something that rewrites the valuation model. This morning it happened again. On March 22, 2026, Tesla’s Terafab chip factory was officially announced — a $20 billion joint venture with SpaceX and xAI targeting 100–200 billion AI chips per year. If execution holds, it’s the most consequential structural announcement for TSLA’s long-term margins in the company’s history.
Here’s my honest take — not hype, not dismissal — just what changed and what it means for income investors who own the stock and use options to harvest yield from it.
TLDR
- Terafab is a $20B joint Tesla/SpaceX/xAI chip factory in Travis County, Texas — targeting 100–200B AI and robotics chips per year starting 2027.
- The real story: vertical chip integration eliminates TSLA’s dependence on Nvidia and TSMC for Cybercab and Optimus — directly expanding margins once operational.
- This is the Apple Silicon moment for Tesla, but 2027 is still 12+ months away and execution risk is real.
- For covered call holders: a stronger upside thesis means selling calls at tight strikes gets riskier — widen those strikes.
- Near-term catalyst to watch: Cybercab commercial launch Q2 2026, not the fab timeline.
What Terafab Actually Is — and Why the Announcement Matters Today
Tesla, SpaceX, and xAI are jointly building a $20 billion chip fabrication facility in Travis County, Texas — adjacent to Tesla’s existing Gigafactory East campus. Production is targeted for 2027 with annual capacity of 100 to 200 billion chips. The chip types are specifically AI processors, robotics chips, data center hardware, and space-based computing silicon — the exact components Tesla currently sources from Nvidia and TSMC to power Cybercab, Optimus humanoid robots, and xAI’s Grok compute infrastructure.
The analogy I keep coming back to is Apple’s transition from Intel to its own Silicon. For years, Apple paid Intel a margin on every Mac. When Apple switched to M-series chips — designed in-house — hardware gross margins expanded noticeably. Apple captured the value it had been paying a third party. Terafab is Tesla’s version of that play, except they’re not just designing chips in-house; they’re building the factory too. That’s a harder lift, and also a bigger potential payoff if they pull it off.
The Margin Story: What Changes When Chips Go In-House
Tesla’s core challenge over the past two years has been this: they’re building products that require massive AI compute, but the chips come from Nvidia — which has meaningful pricing power right now. Every Cybercab requires AI processors. Every Optimus unit requires embedded chips for perception, motion planning, and motor control. If Tesla pays market rates to Nvidia at scale, the robotaxi margin gets compressed before the fleet even launches commercially.
Terafab changes that equation. Once the fab is operational in 2027, Tesla’s chip costs shift from an external line item (Nvidia captures the margin) to an internal cost of goods (Tesla captures the margin). At 100–200 billion chips per year, even a modest per-chip cost advantage translates to billions in annual savings when Cybercab and Optimus are at scale.
The timing is critical: Cybercab launches commercially Q2 2026 — before Terafab is live. So the early Cybercab fleet runs on externally sourced chips. But by the time the robotaxi business is operating at real scale — 2028, 2029 — Terafab should be supplying it. Anyone pricing in Terafab benefits for this year’s earnings is getting ahead of themselves. This is a 2027–2029 margin story, not a 2026 story.
My take: TSLA remains a strong covered call candidate right now — the volatility is high and premiums are meaningful. But Terafab shifts the long-term upside calculus, which affects where I set my strikes. If you’re accessing TSLA through options, make sure your platform has solid options tools.
Why Terafab Changes the Covered Call Calculus
I want to be direct about something that matters for income investors: I sell covered calls on TSLA regularly. Terafab just moved the needle on how I’ll do that going forward.
When I sell a covered call on TSLA, I’m saying: I don’t think this stock is going to rip past my strike price in the next 30 days. If I’m wrong, I get called away and miss the upside above that strike. The premium I collect is compensation for capping that potential gain.
When the long-term thesis gets materially stronger — which Terafab does, conditional on execution — the risk of getting called away on an underpriced strike increases. The stock has more legitimate reasons to run hard. Which means I need to either sell at higher strikes (accepting lower premiums) or accept capping significant upside cheaply.
I’ve been thinking about the real tradeoffs between covered call income and buy-and-hold upside more than usual lately. TSLA is one of the few positions where the covered call income has been genuinely meaningful — 2–4% monthly in some months given the IV. But a stock with a real margin inflection in the pipeline can run in ways that make those premiums look small in hindsight. I’m not abandoning the strategy; I’m widening my strikes to preserve more of the potential upside.
The Joint Venture Structure: Why Tesla Doesn’t Carry This Alone
The three-company structure here is unusual and worth understanding. This isn’t Tesla alone funding a $20B fab. Tesla, SpaceX, and xAI are each sharing capital and using the output:
- Tesla gets AI processors and robotics chips for Cybercab and Optimus
- SpaceX gets space-based computing silicon for Starlink and Starship systems
- xAI gets compute infrastructure for Grok and future AI training without dependency on AWS or Azure
From a capital allocation standpoint, this structure actually reduces the risk for TSLA shareholders. Instead of Tesla alone funding a $20B fab that may sit underutilized in the early ramp, three different businesses share the fixed cost and cover excess capacity with their own demand. The risk of underutilization is distributed.
What I don’t yet know — and what matters — is the exact capital split. If Tesla is funding 70% of a joint venture for three companies, that’s a materially different risk profile than equal thirds. These details will surface in filings, and I’ll be watching them closely.
Execution Risk: What Terafab Is Not
I’ve already seen people on X treating this like Nvidia is dead and TSMC is irrelevant. Let me push back on that.
Fab production is brutally hard. Semiconductor manufacturing has some of the highest defect rates of any industrial process. Yield rates on new fabs — the percentage of chips that come off the line without defects — can be devastatingly low in early production. TSMC has been doing this for decades and still faces yield challenges on leading-edge nodes. A 2027 production start is the optimistic target; 2028 is probably the realistic one.
Tesla will still need Nvidia through 2026 and into 2027. Cybercab is launching Q2 2026 on externally sourced chips. Anyone saying Terafab means Tesla is off Nvidia immediately is wrong.
Geopolitical and regulatory risk is real. EUV lithography equipment (from ASML) is export-controlled. Permitting for a $20B facility in Texas takes time. Workforce requirements for semiconductor manufacturing are specialized and not easily filled overnight.
The way I think about this: I manage position sizing based on conviction and volatility. For how I actually size positions in volatile, thesis-driven assets, the principle holds here — don’t size Terafab as though execution is guaranteed. Size it as a probability-weighted option on a long-term margin thesis with real uncertainty attached.
What the AI Infrastructure Thesis Gets Right
The argument for TSLA as an AI infrastructure company — rather than primarily a car company — has been building for two years. The car business generates cash that funds the AI stack: FSD, Optimus, Cybercab. Each of those products requires chips. Controlling the chip supply chain is the logical next step once you’ve committed to those products at scale.
Terafab is the evidence that Tesla is serious about this thesis as a capital allocation priority, not just a narrative. Apple didn’t announce Apple Silicon and then find reasons to delay indefinitely. They spent years doing it and then executed. Whether Tesla can do the same in a more complex manufacturing environment is the open question — but the announcement today is consistent with a company that intends to follow through.
What I’m Actually Doing With My Position
I’m not changing my position today based on the announcement alone. Here’s what I am doing:
Covered calls: Moving strikes up by roughly one increment. Instead of selling slightly OTM calls, I’m giving the stock more room to run before assignment risk bites me. Premiums will be lower, but I’m preserving upside during what could be a multi-catalyst period (Cybercab Q2 + Terafab narrative building).
Equity position: Holding. This announcement doesn’t make me want to sell, and it doesn’t make me want to pile in aggressively right now. The Cybercab Q2 launch is the real near-term test. If that goes well, I’ll revisit position size.
Covered call ETFs (TSLW and similar): These make the covered call decision at scale on my behalf. Given the stronger upside thesis, I’m slightly less enthusiastic about holding these at full weight while the Terafab/Cybercab catalysts are pending — they’ll cap upside that I might want to capture through the equity directly. This is the exact tradeoff I’ve written about when balancing YieldMax ETF income against underlying appreciation — the math is the same, just applied to TSLA instead of BTC.
The Bottom Line on Terafab and TSLA in 2026
Terafab is a legitimate strategic announcement that, if executed, changes Tesla’s margin structure in the robotaxi and robotics era starting in 2027. It’s the Apple Silicon moment for TSLA — except Apple had more chip design experience, a cleaner supply chain, and a simpler manufacturing path. Tesla is taking a harder route with a higher potential payoff.
The 2026 story for TSLA is still Cybercab launch, not Terafab. Watch Q2 2026 for Cybercab commercial rollout — that’s the near-term proof of concept for the entire robotaxi thesis. Terafab is the 2027–2029 margin expansion story.
For covered call income investors: this is the moment to widen your strikes. Don’t sell your upside cheaply when legitimate catalysts are building.
My take: If you want to trade TSLA or run covered calls on it, Robinhood has solid zero-commission options tools and is where I execute most of my equity options trades.
My take: For the crypto side of my portfolio alongside TSLA — BTC, ETH, covered call ETFs on crypto — I still use Coinbase Advanced Trade. Low maker fees, solid custody, and the exchange that institutional flows move through when regulatory clarity matters.
FAQ
What is Tesla Terafab?
Terafab is a $20 billion chip fabrication facility being built jointly by Tesla, SpaceX, and xAI in Travis County, Texas. It targets 100–200 billion AI processors, robotics chips, and data center silicon per year, with production expected to begin in 2027. The facility is designed to eliminate Tesla’s dependence on Nvidia and TSMC for chips used in Cybercab, Optimus, and xAI infrastructure.
How does Terafab affect TSLA stock in 2026?
Terafab’s direct financial impact won’t be felt until 2027 at the earliest. The more relevant 2026 catalyst for TSLA is the Cybercab commercial launch targeted for Q2 2026. Terafab is a long-term margin story, not a 2026 earnings driver. The announcement does, however, strengthen the long-term upside thesis, which is relevant for anyone managing options positions on the stock today.
Does Terafab mean Tesla won’t need Nvidia anymore?
Not immediately. Tesla continues to rely on externally sourced chips through 2026 and likely into 2027. Terafab is a vertical integration play that takes effect once production starts — Nvidia dependency persists in the near term. Anyone saying Terafab makes Nvidia irrelevant now is wrong.
How should covered call sellers adjust after the Terafab announcement?
A stronger long-term upside thesis means you should be more conservative about selling calls close to the current price. Widening strikes preserves more of the potential upside if Cybercab and Terafab catalysts accelerate the stock — the lower premiums you collect on wider strikes are the cost of staying long the upside optionality.
Is Terafab similar to Apple Silicon?
The analogy is apt. Apple moved all Macs off Intel processors after years of designing its own M-series chips in-house. The transition improved Apple’s hardware margins by eliminating Intel’s margin on each unit sold. Terafab aims for the same outcome — capturing chip margin rather than paying it to TSMC or Nvidia. The key difference is that Apple used TSMC’s existing foundry infrastructure rather than building its own fab, which is significantly harder and riskier.
